Physician profile
Steven Silberfarb
NPI 1730119181
$2,004.60
in general payments reported to CMS, 2019-2025
12 companies · $32.57 in 2025
The $32.57 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $112 · 2021: $16.03 · 2022: $1,290 · 2023: $166 · 2024: $74.67 · 2025: $32.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $273.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Southern Edge Orthopaedics, INC. | $1,200.00 | 2022 | |
| Stryker Corporation | $255.97 | 2019-2025 | Accolade, Mako |
| Spineology INC. | $195.92 | 2019-2020 | |
| Ossdsign USA Incorporated | $105.24 | 2023 | |
| Si-Bone, INC. | $71.60 | 2019 | |
| Innovation Technologies INC | $36.87 | 2023 | Irrisept |
| Amgen INC. | $34.82 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $24.26 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $24.13 | 2023 | Seglentis |
| Vericel Corporation | $22.28 | 2024 | Maci |
| Providence Medical Technology, INC. | $17.48 | 2022 | |
| Avanos Medical | $16.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Silberfarb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.